Patent: 8,501,240
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 8,501,240
Title: | Compositions comprising an active agent |
Abstract: | The present invention provides a highly dispersible formulation comprising an active agent and a dipeptide or tripeptide comprising at least two leucyl residues. The composition of the invention possesses superior aerosol properties and is thus preferred for aerosolized administration to the lung. Also provided are a method for (i) increasing the dispersibility of an active-agent containing formulation for administration to the lung, and (ii) delivery of the composition to the lungs of a subject. |
Inventor(s): | Kuo; Mei-chang (Palo Alto, CA), Lechuga-Ballesteros; David (San Jose, CA) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 12/343,365 |
Patent Claims: | see list of patent claims |
Details for Patent 8,501,240
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | 05/23/1994 | ⤷ Try a Trial | 2019-10-29 |
Genzyme Corporation | CEREZYME | imiglucerase | For Injection | 020367 | 09/22/1999 | ⤷ Try a Trial | 2019-10-29 |
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2019-10-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |